Enveric Biosciences, Inc. (ENVB)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
Aug 24, 16:00
1.48
+0.07
(+4.96%)
After-Hours: 20:00
Enveric Biosciences Total Assets (Quarterly) : 8.944M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.944M |
| March 31, 2026 | 5.522M |
| December 31, 2025 | 5.096M |
| September 30, 2025 | 4.362M |
| June 30, 2025 | 3.548M |
| March 31, 2025 | 5.102M |
| December 31, 2024 | 3.082M |
| September 30, 2024 | 4.790M |
| June 30, 2024 | 6.052M |
| March 31, 2024 | 8.850M |
| December 31, 2023 | 6.118M |
| September 30, 2023 | 6.619M |
| June 30, 2023 | 9.800M |
| March 31, 2023 | 15.85M |
| December 31, 2022 | 19.55M |
| September 30, 2022 | 30.86M |
| June 30, 2022 | 28.57M |
| March 31, 2022 | 32.18M |
| December 31, 2021 | 26.72M |
| September 30, 2021 | 69.76M |
| June 30, 2021 | 23.70M |
| March 31, 2021 | 25.79M |
| December 31, 2020 | |
| September 30, 2020 | 27.99M |
| June 30, 2020 | 27.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 27.14M |
| December 31, 2019 | 25.01M |
| September 30, 2019 | 26.66M |
| June 30, 2019 | 29.48M |
| March 31, 2019 | 30.51M |
| December 31, 2018 | 29.64M |
| September 30, 2018 | 45.90M |
| June 30, 2018 | 45.54M |
| March 31, 2018 | 47.92M |
| December 31, 2017 | 52.20M |
| September 30, 2017 | 47.14M |
| June 30, 2017 | 47.29M |
| March 31, 2017 | 49.68M |
| December 31, 2016 | 39.51M |
| September 30, 2016 | 38.12M |
| June 30, 2016 | 15.14M |
| March 31, 2016 | 12.63M |
| December 31, 2015 | 13.83M |
| September 30, 2015 | 21.21M |
| June 30, 2015 | 10.44M |
| March 31, 2015 | 0.0039M |
| December 31, 2014 | 0.0051M |
| September 30, 2014 | 0.0091M |
| June 30, 2014 | 0.012M |
| March 31, 2014 | 0.0267M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| LENZ Therapeutics, Inc. | 236.60M |
| Impact BioMedical, Inc. | 16.74M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.8615M |
| Shareholders Equity (Quarterly) | 8.082M |
| Current Ratio | 10.21 |